grace targeted therapies lung cancer 2021 - data learned from ensartinib for ros1 in clinical trial?
Published 2 years ago • 35 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer
-
14:57
grace targeted therapies lung cancer 2021 - standards & novel therapies sensitizing mutations, pt 1
-
17:40
liquid biopsies: current applications - grace targeted therapies in lung cancer patient forum 2021
-
7:27
intro and cancer 101 - grace targeted therapies in lung cancer patient forum 2021
-
14:33
grace targeted therapies lung cancer 2021 - targeted therapies in oligo-metastatic disease
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
17:53
grace targeted therapies lung cancer 2021 - genotype directed therapy: role in earlier stage disease
-
4:31
grace targeted therapies lung cancer 2021 -recommended 2nd line & timing, stage 3 ros-1 lung cancer?
-
4:40
grace targeted therapies in lung cancer 2021 - cost & care for liquid & tissue biopsy monitoring
-
11:49
grace targeted therapies lung cancer 2021 - online communities, education & partnership in research
-
3:09
grace targeted therapies lung cancer 2021 - best treatment patient with a designated kras mutation
-
4:06
grace targeted therapies lung cancer 2021 options after progression on alectinib?
-
2:39
grace targeted therapies lung cancer 2021 - return to alectinib -progression on lorlatinib in alk
-
2:58
grace targeted therapies lung cancer 2021 - is there a benefit of having higher dose osimertinib?
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
14:05
grace targeted therapies lung cancer 2021 - standards & novel therapies sensitizing mutations, pt 2
-
4:02
grace targeted therapies in lung cancer 2021 - future, telemedicine & interstate treatment